EUVIMEDEUVIMED entdecken
Crossref

Insulin Delivery Systems for Controlling Diabetes

Jaleh Varshosaz

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery · 2007

DOI: 10.2174/187221407779814624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 2007. Verfasst von Jaleh Varshosaz. Die Arbeit wurde bisher 15-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The goal of all drug delivery systems is to deploy medications intact to specifically targeted parts of the body through a medium that can control the therapys administration by means of either a physiological or chemical trigger. The polypeptide insulin is the primary hormone responsible for controlling the transport, utilization and storage of glucose in the body. Due to the inconvenience of insulin injections, various approaches have been attempted to formulate insulin for administration by non-injectable routes. Different approaches to deliver insulin including transdermal, transmucosal, pulmonary route using dry aerosols and inhalers, smart hydrogels, nasal delivery, oral delivery, and treatment of diabetes with synthetic beta cells, has resulted in recent developments in treatment of diabetes. Among the latest patent approaches are delivering into the subject a genetic construct comprising a coding sequence for a human proinsulin operably connected a promoter functional in the host cells. Polypeptides having activity of human neurogenin3 (hNgn3), and nucleic acid encoding such polypeptide are among the other inventions that use of islet transcription factors such as hNgn3 to facilitate production of pancreatic islet cells from progenitor cells, and to facilitate insulin delivery by production of islet cells so produced. Keywords: Insulin, Hydrogels, Nasal delivery, PEG-insulin, Blood glucose level, Aerosols, Transdermal

Zitieren

APA

Varshosaz, J. (2007). Insulin Delivery Systems for Controlling Diabetes. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery. https://doi.org/10.2174/187221407779814624

Vancouver

Varshosaz J. Insulin Delivery Systems for Controlling Diabetes. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery. 2007. doi:10.2174/187221407779814624

BibTeX
@article{Varshosaz2007,
  author = {Varshosaz, Jaleh},
  title = {Insulin Delivery Systems for Controlling Diabetes},
  journal = {Recent Patents on Endocrine, Metabolic & Immune Drug Discovery},
  year = {2007},
  doi = {10.2174/187221407779814624}
}
Kostenlos starten →